Organovo Holdings, Inc. (ONVO) Financial Statements (2024 and earlier)

Company Profile

Business Address 11555 SORRENTO VALLEY ROAD
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End March 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
3/31/2023
12/31/2022
MRQ
3/31/2022
3/31/2021
3/31/2020
3/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments16,00120,79628,67537,36427,35636,477
Cash and cash equivalents15,30120,19628,67537,36427,35636,477
Short-term investments 700600    
Receivables15276  111503
Inventory, net of allowances, customer advances and progress billings      490
Inventory      490
Other undisclosed current assets8957428581,0348511,104
Total current assets:17,04821,61429,53338,39828,31838,574
Noncurrent Assets
Operating lease, right-of-use asset1,7051,8032,153  
Property, plant and equipment902742662381 1,832
Restricted cash and investments100143100100 79
Other noncurrent assets    1,027123138
Other undisclosed noncurrent assets55877784811  
Total noncurrent assets:3,2653,4653,7631,5191232,049
TOTAL ASSETS:20,31325,07933,29639,91728,44140,623
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,1798889047211,8103,177
Accounts payable331242415281720628
Accrued liabilities2,8486464894401,0902,549
Deferred rent credit      35
Contract with customer, liability525
Other liabilities      
Other undisclosed current liabilities492488479   
Total current liabilities:3,6711,3761,3837211,8103,737
Noncurrent Liabilities
Long-term debt and lease obligation:   1,704   
Liabilities, other than long-term debt1,3131,414   588
Deferred rent credit      588
Operating lease, liability1,3131,4141,704  
Other undisclosed noncurrent liabilities   (1,704)   
Total noncurrent liabilities:1,3131,4141,704  588
Total liabilities:4,9842,7903,0877211,8104,325
Equity
Equity, attributable to parent15,32922,28930,20939,19626,63136,298
Common stock9999131124
Treasury stock, value(1)(1)(1)(1)  
Additional paid in capital340,317339,817337,940335,479305,965296,929
Accumulated other comprehensive income23    
Accumulated deficit(324,998)(317,539)(307,739)(296,291)(279,465)(260,755)
Total equity:15,32922,28930,20939,19626,63136,298
TOTAL LIABILITIES AND EQUITY:20,31325,07933,29639,91728,44140,623

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
3/31/2023
12/31/2022
TTM
3/31/2022
3/31/2021
3/31/2020
3/31/2019
Revenues3701,7081,500 2,1963,091
Cost of revenue     (300)(500)
Cost of goods and services sold     (328)(482)
Gross profit:3702081,500 1,8962,591
Operating expenses(18,101)(8,911)(12,979)(16,826)(23,343)(29,883)
Other undisclosed operating income (loss) 1,500  (28)18
Operating loss:(17,731)(7,203)(11,479)(16,826)(21,475)(27,274)
Nonoperating income4741683322,767642
Investment income, nonoperating454272815594705
Other nonoperating income  192561,535 
Loss from continuing operations before income taxes:(17,257)(7,035)(11,446)(16,824)(18,708)(26,632)
Income tax expense(2)(2)(2)(2)(2)(3)
Loss from continuing operations:(17,259)(7,037)(11,448)(16,826)(18,710)(26,635)
Loss before gain (loss) on sale of properties:(3,773)(11,448)(16,826)(18,710)(26,635)
Other undisclosed net income  19    
Net loss available to common stockholders, diluted:(17,259)(7,018)(11,448)(16,826)(18,710)(26,635)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
3/31/2023
12/31/2022
TTM
3/31/2022
3/31/2021
3/31/2020
3/31/2019
Net loss:(17,259)(7,018)(11,448)(16,826)(18,710)(26,635)
Comprehensive loss:(17,259)(7,018)(11,448)(16,826)(18,710)(26,635)
Other undisclosed comprehensive income, net of tax, attributable to parent23    
Comprehensive loss, net of tax, attributable to parent:(17,257)(7,015)(11,448)(16,826)(18,710)(26,635)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: